Queensland injecting drug survey (QuIDS)
QuIDS is a collaboration between QADREC, QH, the Queensland Aboriginal Health Council (QAIHC) and the National Centre for HIV Epidemiology and Clinical Research (NCHECR) at the University of New South Wales
Funding: 2010 - $200,000 from Queensland Health’s Aboriginal and Torres Strait Islander Health Development Branch
Project Advisory Group: Coralie Ober, Jake Najman, Andrew Young (QH), Robert Kemp (QH), James Ward (NCHECR), Vanessa Gela (QuIHN), Sidney Williams (QAIHC
Chief Investigators: Jake Najman, Sidney Williams, James Ward, Robert Kemp
Associate Investigators: Andrew Smirnov, Abhi Dev, Fairlie McIlwraith
The project also relies on the support and involvement of a number of local organisations throughout Queensland, including; needle and syringe programs, community controlled organisations, Queensland Injectors Health Network (QuIHN), and Alcohol, Tobacco and Other Drugs (ATODS).
Injecting drug use is an important health issue affecting both individuals and communities throughout Queensland. While there is growing concern about injecting drug use among people of Aboriginal and/or Torres Strait Islander descent, there is little quantitative research in this area. Key policy initiatives at the national and state levels have identified Aboriginal and Torres Strait Islander people as a priority population for research. The project recruited and conducted structured interviews with 570 people who inject drugs (PWID), from a number of urban and regional centres throughout Queensland. Participants have completed a questionnaire about patterns of use, levels of drug dependence, blood borne viruses, risky behaviour and the different social, cultural and health issues that may relate to the outcomes of injecting drug use.
This study is unique in its inclusion of a matched comparison group; approximately half of the sample identified as Indigenous allowing for important comparisons to be made between groups. The study aims include: a) evaluating patterns of Indigenous injecting drug use in Queensland, including the nature of dependence and transitions to injecting; b) reviewing demographic and social characteristics of diverse user populations; c) examining the mental health status of Indigenous PWID; d) assessing the prevalence of blood-borne viral infections and other injection-related health issues in both Indigenous and non-Indigenous PWID; d) assessing behavioural aspects of injecting drug use, including the relationship between injecting drug use and engagement in other illicit activities; (d) determining 'user-understanding' of injection and associated risks; (e) evaluating 'user-perception' of existing programs and services, including the needle and syringe programs. Comparisons for all aims will be made between Indigenous and non-Indigenous PWID, and findings will support development of relevant services and education initiatives.
• Evaluate the patterns of Indigenous injecting drug use in Queensland, including the nature of dependence and transitions to injecting
• Review demographic and social characteristics of diverse user populations
• Review the mental health status of Indigenous PWID
• Assess the prevalence of blood-borne viral infections and other injection related health issues in both Indigenous and non-Indigenous PWID
• Assess behavioural aspects of injecting drug use, including the relationship between injecting drug use and engagement in other illicit activities
• Determine 'user-understanding' of injection and associated risks
• Evaluate 'user-perception' of existing programs and services, including the needle and syringe programs
Comparisons for all aims will be made between Indigenous and non-Indigenous PWID.
• Virological analysis of blood samples
• Paper submitted for publication:
Smirnov A, Kemp R, Ward J, Henderson S, Williams S, Dev A, & Najman J. (2015) A comparison of drug dependence in a Queensland (Australia) sample of Indigenous and non-Indigenous people who inject drugs.
• Further dissemination of findings to the AOD and Indigenous health workforce, including conference presentations.
• Completion of report, and submission to Queensland Health’s Aboriginal and Torres Strait Islander Health Development Branch
• Distribution of report to key stakeholders and interested parties.
• Publication of additional peer-reviewed papers.